{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:32:49Z","timestamp":1792171969608,"version":"4.4.0"},"reference-count":195,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"6","license":[{"start":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T00:00:00Z","timestamp":1717545600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2024,6,5]]},"DOI":"10.1167\/iovs.65.6.8","type":"journal-article","created":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T12:27:16Z","timestamp":1717590436000},"page":"8","source":"Crossref","is-referenced-by-count":10,"title":["An Overview of Optic Pathway Glioma With Neurofibromatosis Type 1: Pathogenesis, Risk Factors, and Therapeutic Strategies"],"prefix":"10.1167","volume":"65","author":[{"given":"Ying","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengfang","family":"Ge","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renbing","family":"Jia","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yefei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianqun","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"issue":"5","key":"bib1","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/0039-6257(94)90173-2","article-title":"Gliomas of the anterior visual pathway","volume":"38","author":"Dutton","year":"1994","journal-title":"Surv Ophthalmol"},{"issue":"6","key":"bib2","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 world health organization classification of tumors of the central nervous system: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol (Berl)"},{"issue":"7","key":"bib3","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1002\/pbc.v53:7","article-title":"Natural history and outcome of optic pathway gliomas in children","volume":"53","author":"Nicolin","year":"2009","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"bib4","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/ana.v61:3","article-title":"Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations","volume":"61","author":"Listernick","year":"2007","journal-title":"Ann Neurol"},{"issue":"2","key":"bib5","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/ana.v41:2","article-title":"Optic pathway gliomas in children with neurofibromatosis. 1. Consensus statement from the NF1 optic pathway glioma task force","volume":"41","author":"Listernick","year":"1997","journal-title":"Ann Neurol"},{"issue":"1","key":"bib6","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0022-3476(94)70122-9","article-title":"Natural history of optic pathway tumors in children with neurofibromatosis type I: a longitudinal study","volume":"125","author":"Listernick","year":"1994","journal-title":"J Pediatr"},{"issue":"5","key":"bib7","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/S0022-3476(89)80137-4","article-title":"Optic gliomas in children with neurofibromatosis type 1","volume":"114","author":"Listernick","year":"1989","journal-title":"J Pediatr"},{"issue":"Pt 1","key":"bib8","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/brain\/awg016","article-title":"Prognostic factors of CNS tumours in neurofibromatosis 1 (NF1): a retrospective study of 104 patients","volume":"126","author":"Guillamo","year":"2003","journal-title":"Brain J Neurol"},{"issue":"3","key":"bib9","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.ajo.2003.09.055","article-title":"Optic radiation involvement in optic pathway gliomas in neurofibromatosis","volume":"137","author":"Liu","year":"2004","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"bib10","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.jpeds.2015.07.001","article-title":"The use of magnetic resonance imaging screening for optic pathway gliomas in children with neurofibromatosis type 1","volume":"167","author":"Prada","year":"2015","journal-title":"J Pediatr"},{"key":"bib11","article-title":"Serial MRIs provide novel insight into natural history of optic pathway gliomas in patients with neurofibromatosis 1","volume":"13:62","author":"Sellmer","year":"2018","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"bib12","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/jnr.v97.1","article-title":"Insights into optic pathway glioma vision loss from mouse models of neurofibromatosis type 1","volume":"97","author":"Freret","year":"2019","journal-title":"J Neurosci Res"},{"issue":"6","key":"bib13","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1177\/0883073818758737","article-title":"Isolated optic nerve glioma in children with and without neurofibromatosis: retrospective characterization and analysis of outcomes","volume":"33","author":"Hamideh","year":"2018","journal-title":"J Child Neurol"},{"issue":"7","key":"bib14","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1177\/08830738030180070401","article-title":"Optic pathway gliomas in children with and without neurofibromatosis 1","volume":"18","author":"Czyzyk","year":"2003","journal-title":"J Child Neurol"},{"issue":"5","key":"bib15","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/S0022-3476(95)70159-1","article-title":"Optic pathway tumors in children: the effect of neurofibromatosis type 1 on clinical manifestations and natural history","volume":"127","author":"Listernick","year":"1995","journal-title":"J Pediatr"},{"issue":"1","key":"bib16","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/s41390-022-02098-5","article-title":"Optic pathway glioma and endocrine disorders in patients with and without NF1","volume":"93","author":"Gil Margolis","year":"2023","journal-title":"Pediatr Res"},{"key":"bib17","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.wneu.2022.04.033","article-title":"Visual outcomes after treatment for sporadic optic pathway gliomas in pediatric patients: a systematic review","volume":"164","author":"Shlobin","year":"2022","journal-title":"World Neurosurg"},{"key":"bib18","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.critrevonc.2016.05.008","article-title":"Neurofibromatosis type 1 associated low grade gliomas: a comparison with sporadic low grade gliomas","volume":"104","author":"Helfferich","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"issue":"21","key":"bib19","doi-asserted-by":"publisher","first-page":"8673","DOI":"10.1158\/0008-5472.CAN-08-2097","article-title":"Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas","volume":"68","author":"Jones","year":"2008","journal-title":"Cancer Res"},{"issue":"20","key":"bib20","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1038\/onc.2009.73","article-title":"Oncogenic RAF1 rearrangement and a novel BRAF mutation as alternatives to KIAA1549:BRAF fusion in activating the MAPK pathway in pilocytic astrocytoma","volume":"28","author":"Jones","year":"2009","journal-title":"Oncogene"},{"issue":"23","key":"bib21","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1101\/gad.200907.112","article-title":"Pediatric glioma-associated KIAA1549:BRAF expression regulates neuroglial cell growth in a cell type-specific and mTOR-dependent manner","volume":"26","author":"Kaul","year":"2012","journal-title":"Genes Dev"},{"issue":"4","key":"bib22","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/S0002-9394(00)00852-7","article-title":"Visual loss in children with neurofibromatosis type 1 and optic pathway gliomas: relation to tumor location by magnetic resonance imaging","volume":"131","author":"Balcer","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"bib23","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ajo.2020.03.053","article-title":"Neurofibromatosis type 1-associated optic pathway glioma in children: a follow-up of 10 years or more","volume":"221","author":"Kinori","year":"2021","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"bib24","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/S0022-3476(95)70449-3","article-title":"Precocious puberty in children with neurofibromatosis type 1","volume":"126","author":"Habiby","year":"1995","journal-title":"J Pediatr"},{"issue":"3","key":"bib25","doi-asserted-by":"publisher","first-page":"747","DOI":"10.3390\/cancers14030747","article-title":"A 40-year cohort study of evolving hypothalamic dysfunction in infants and young children (<3 years) with optic pathway gliomas","volume":"14","author":"Picariello","year":"2022","journal-title":"Cancers"},{"issue":"1","key":"bib26","first-page":"1","article-title":"Neurofibromatosis type 1","volume":"3","author":"Gutmann","year":"2017","journal-title":"Nat Rev Dis Primer"},{"issue":"6","key":"bib27","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1093\/neuonc\/nos076","article-title":"Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis","volume":"14","author":"Fisher","year":"2012","journal-title":"Neuro-Oncol"},{"issue":"12","key":"bib28","first-page":"1807","article-title":"Prognostic factors for progression of childhood optic pathway glioma: a systematic review","volume":"42","author":"Opocher","year":"2006","journal-title":"Eur J Cancer Oxf Engl 1990"},{"issue":"8","key":"bib29","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1093\/neuonc\/noac013","article-title":"Risk factors for treatment-refractory and relapsed optic pathway glioma in children with neurofibromatosis type 1","volume":"24","author":"Kotch","year":"2022","journal-title":"Neuro-Oncol"},{"issue":"2","key":"bib30","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/ana.v75.2","article-title":"Sex is a major determinant of neuronal dysfunction in neurofibromatosis type 1","volume":"75","author":"Diggs-Andrews","year":"2014","journal-title":"Ann Neurol"},{"key":"bib31","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1097\/WNO.0000000000000550","article-title":"Optic pathway gliomas in neurofibromatosis type 1: an update: surveillance, treatment indications, and biomarkers of vision","volume":"37","author":"de Blank","year":"2017","journal-title":"J Neuroophthalmol"},{"issue":"1","key":"bib32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11060-012-0944-y","article-title":"Visual acuity in children with low grade gliomas of the visual pathway: implications for patient care and clinical research","volume":"110","author":"Avery","year":"2012","journal-title":"J Neurooncol"},{"issue":"16","key":"bib33","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1200\/JCO.2005.03.8349","article-title":"Second primary tumors in neurofibromatosis I patients treated for optic glioma: substantial risks after radiotherapy","volume":"24","author":"Sharif","year":"2006","journal-title":"J Clin Oncol"},{"issue":"3","key":"bib34","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/(ISSN)1531-8249","article-title":"Radiation-induced cerebral vasculopathy in children with neurofibromatosis and optic pathway glioma","volume":"45","author":"Grill","year":"1999","journal-title":"Ann Neurol"},{"issue":"4","key":"bib35","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1053\/ejpn.2002.0595","article-title":"Visual pathway glioma in children treated with chemotherapy","volume":"6","author":"Demaerel","year":"2002","journal-title":"Eur J Paediatr Neurol EJPN Off J Eur Paediatr Neurol Soc"},{"issue":"3","key":"bib36","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1023\/A:1005866021835","article-title":"Cisplatin\/vincristine chemotherapy for hypothalamic\/visual pathway astrocytomas in young children","volume":"37","author":"Kato","year":"1998","journal-title":"J Neurooncol"},{"issue":"4","key":"bib37","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/neuonc\/2.4.213","article-title":"Carboplatin is effective therapy for young children with progressive optic pathway tumors: a Pediatric Oncology Group phase II study","volume":"2","author":"Mahoney","year":"2000","journal-title":"Neuro-Oncol"},{"issue":"2","key":"bib38","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3928\/01913913-20210720-02","article-title":"Visual outcomes of optic pathway glioma treated with chemotherapy in neurofibromatosis type 1","volume":"59","author":"Jos\u00e9","year":"2022","journal-title":"J Pediatr Ophthalmol Strabismus"},{"issue":"4","key":"bib39","doi-asserted-by":"publisher","first-page":"e169","DOI":"10.1212\/NXG.0000000000000169","article-title":"Updated nomenclature for human and mouse neurofibromatosis type 1 genes","volume":"3","author":"Anastasaki","year":"2017","journal-title":"Neurol Genet"},{"issue":"1","key":"bib40","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/0092-8674(90)90252-A","article-title":"Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus","volume":"62","author":"Viskochil","year":"1990","journal-title":"Cell"},{"issue":"4965","key":"bib41","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1126\/science.2134734","article-title":"Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients","volume":"249","author":"Wallace","year":"1990","journal-title":"Science"},{"issue":"4","key":"bib42","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/0092-8674(90)90149-9","article-title":"The catalytic domain of the neurofibromatosis type 1 gene product stimulates Ras GTPase and complements IRA mutants of S. cerevisiae","volume":"63","author":"Xu","year":"1990","journal-title":"Cell"},{"issue":"4","key":"bib43","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/0092-8674(90)90151-4","article-title":"The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins","volume":"63","author":"Ballester","year":"1990","journal-title":"Cell"},{"issue":"4","key":"bib44","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/0092-8674(90)90150-D","article-title":"The GAP-related domain of the neurofibromatosis type 1 gene product interacts with Ras p21","volume":"63","author":"Martin","year":"1990","journal-title":"Cell"},{"issue":"4","key":"bib45","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s00401-019-02002-2","article-title":"An update on the central nervous system manifestations of neurofibromatosis type 1","volume":"139","author":"Nix","year":"2020","journal-title":"Acta Neuropathol (Berl)"},{"issue":"4","key":"bib46","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1073\/pnas.68.4.820","article-title":"Mutation and cancer: statistical study of retinoblastoma","volume":"68","author":"Ag","year":"1971","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"bib47","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41591-018-0263-8","article-title":"The molecular landscape of glioma in patients with neurofibromatosis 1","volume":"25","author":"D'Angelo","year":"2019","journal-title":"Nat Med"},{"issue":"4","key":"bib48","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.ccell.2020.03.011","article-title":"Integrated molecular and clinical analysis of 1,000 pediatric low-grade gliomas","volume":"37","author":"Ryall","year":"2020","journal-title":"Cancer Cell"},{"issue":"3","key":"bib49","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1101\/gr.142604.112","article-title":"Somatic neurofibromatosis type 1 (NF1) inactivation characterizes NF1-associated pilocytic astrocytoma","volume":"23","author":"Gutmann","year":"2013","journal-title":"Genome Res"},{"issue":"1","key":"bib50","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1158\/0008-5472.236.65.1","article-title":"Glioma formation in neurofibromatosis 1 reflects preferential activation of K-Ras in astrocytes","volume":"65","author":"Dasgupta","year":"2005","journal-title":"Cancer Res"},{"issue":"7","key":"bib51","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1158\/0008-5472.CAN-04-4058","article-title":"Proteomic analysis reveals hyperactivation of the mammalian target of rapamycin pathway in neurofibromatosis 1-associated human and mouse brain tumors","volume":"65","author":"Dasgupta","year":"2005","journal-title":"Cancer Res"},{"issue":"9","key":"bib52","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1093\/jnen\/59.9.759","article-title":"Loss of neurofibromin is associated with activation of Ras\/MAPK and PI3-K\/AKT signaling in a neurofibromatosis 1 astrocytoma","volume":"59","author":"Lau","year":"2000","journal-title":"J Neuropathol Exp Neurol"},{"issue":"3","key":"bib53","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1177\/1947601911411084","article-title":"Ras in cancer and developmental diseases","volume":"2","author":"Fern\u00e1ndez-Medarde","year":"2011","journal-title":"Genes Cancer"},{"issue":"1","key":"bib54","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.cell.2017.06.009","article-title":"Ras proteins and their regulators in human disease","volume":"170","author":"Simanshu","year":"2017","journal-title":"Cell"},{"issue":"6","key":"bib55","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1093\/neuonc\/nou329","article-title":"Akt- or MEK-mediated mTOR inhibition suppresses Nf1 optic glioma growth","volume":"17","author":"Kaul","year":"2015","journal-title":"Neuro-Oncol"},{"issue":"1","key":"bib56","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1172\/JCI60578","article-title":"MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors","volume":"123","author":"Jessen","year":"2013","journal-title":"J Clin Invest"},{"issue":"1","key":"bib57","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1172\/JCI63193","article-title":"Sustained MEK inhibition abrogates myeloproliferative disease in Nf1 mutant mice","volume":"123","author":"Chang","year":"2013","journal-title":"J Clin Invest"},{"issue":"4","key":"bib58","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.stem.2007.07.008","article-title":"Neurofibromatosis-1 regulates neuronal and glial cell differentiation from neuroglial progenitors in vivo by both cAMP- and Ras-dependent mechanisms","volume":"1","author":"Hegedus","year":"2007","journal-title":"Cell Stem Cell"},{"issue":"14","key":"bib59","doi-asserted-by":"publisher","first-page":"5717","DOI":"10.1158\/0008-5472.CAN-09-3769","article-title":"Cyclic AMP suppression is sufficient to induce gliomagenesis in a mouse model of neurofibromatosis-1","volume":"70","author":"Warrington","year":"2010","journal-title":"Cancer Res"},{"issue":"12","key":"bib60","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1038\/s41588-019-0531-7","article-title":"Stalled developmental programs at the root of pediatric brain tumors","volume":"51","author":"Jessa","year":"2019","journal-title":"Nat Genet"},{"issue":"4","key":"bib61","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1093\/neuonc\/noaa237","article-title":"Temporal, spatial, and genetic constraints contribute to the patterning and penetrance of murine neurofibromatosis-1 optic glioma","volume":"23","author":"Brossier","year":"2021","journal-title":"Neuro-Oncol"},{"issue":"20","key":"bib62","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1016\/j.devcel.2021.08.004","article-title":"Treatment during a developmental window prevents NF1-associated optic pathway gliomas by targeting Erk-dependent migrating glial progenitors","volume":"56","author":"Jecrois","year":"2021","journal-title":"Dev Cell"},{"key":"bib63","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1146\/neuro.1989.12.issue-1","article-title":"The macroglial cells of the rat optic nerve","volume":"12","author":"Miller","year":"1989","journal-title":"Annu Rev Neurosci"},{"issue":"12","key":"bib64","first-page":"1501","article-title":"Development of astrocytes in the vertebrate eye","volume":"243","author":"Tao","year":"2014","journal-title":"Dev Dyn Off Publ Am Assoc Anat"},{"issue":"1","key":"bib65","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ccr.2012.05.036","article-title":"Innate neural stem cell heterogeneity determines the patterning of glioma formation in children","volume":"22","author":"Lee","year":"2012","journal-title":"Cancer Cell"},{"issue":"1","key":"bib66","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13064-016-0075-9","article-title":"Oligodendrocyte development in the embryonic tuberal hypothalamus and the influence of Ascl1","volume":"11","author":"Marsters","year":"2016","journal-title":"Neural Develop"},{"issue":"1","key":"bib67","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11064-017-2404-8","article-title":"Origin of oligodendrocytes in the vertebrate optic nerve: a review","volume":"43","author":"Ono","year":"2018","journal-title":"Neurochem Res"},{"issue":"Pt 6","key":"bib68","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1093\/brain\/awp048","article-title":"Pilocytic astrocytoma of the optic pathway: a tumour deriving from radial glia cells with a specific gene signature","volume":"132","author":"Tchoghandjian","year":"2009","journal-title":"Brain J Neurol"},{"issue":"7","key":"bib69","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1097\/NEN.0b013e31822200aa","article-title":"Comparative characterization of the human and mouse third ventricle germinal zones","volume":"70","author":"Dahiya","year":"2011","journal-title":"J Neuropathol Exp Neurol"},{"issue":"16","key":"bib70","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1101\/gad.261677.115","article-title":"Neurofibromatosis-1 regulation of neural stem cell proliferation and multilineage differentiation operates through distinct Ras effector pathways","volume":"29","author":"Chen","year":"2015","journal-title":"Genes Dev"},{"issue":"24","key":"bib71","first-page":"8573","article-title":"Optic nerve glioma in mice requires astrocyte Nf1 gene inactivation and Nf1 brain heterozygosity","volume":"63","author":"Bajenaru","year":"2003","journal-title":"Cancer Res"},{"issue":"29","key":"bib72","doi-asserted-by":"publisher","first-page":"47206","DOI":"10.18632\/oncotarget.v8i29","article-title":"The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation","volume":"8","author":"Solga","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"bib73","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/onc.2012.580","article-title":"NG2-cells are not the cell of origin for murine neurofibromatosis-1 (Nf1) optic glioma","volume":"33","author":"Solga","year":"2014","journal-title":"Oncogene"},{"issue":"32","key":"bib74","doi-asserted-by":"publisher","first-page":"52474","DOI":"10.18632\/oncotarget.v8i32","article-title":"Whole tumor RNA-sequencing and deconvolution reveal a clinically-prognostic PTEN\/PI3K-regulated glioma transcriptional signature","volume":"8","author":"Pan","year":"2017","journal-title":"Oncotarget"},{"issue":"7229","key":"bib75","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nature07589","article-title":"Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation","volume":"457","author":"Zhu","year":"2009","journal-title":"Nature"},{"issue":"38","key":"bib76","doi-asserted-by":"publisher","first-page":"15996","DOI":"10.1073\/pnas.1019012108","article-title":"Neurofibromatosis-1 regulates mTOR-mediated astrocyte growth and glioma formation in a TSC\/Rheb-independent manner","volume":"108","author":"Banerjee","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"bib77","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1158\/0008-5472.CAN-07-5916","article-title":"Preclinical cancer therapy in a mouse model of neurofibromatosis-1 optic glioma","volume":"68","author":"Hegedus","year":"2008","journal-title":"Cancer Res"},{"issue":"2","key":"bib78","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nn792","article-title":"Neurofibromin regulates G protein-stimulated adenylyl cyclase activity","volume":"5","author":"Tong","year":"2002","journal-title":"Nat Neurosci"},{"issue":"26","key":"bib79","doi-asserted-by":"publisher","first-page":"8949","DOI":"10.1523\/JNEUROSCI.23-26-08949.2003","article-title":"The neurofibromatosis 1 gene product neurofibromin regulates pituitary adenylate cyclase-activating polypeptide-mediated signaling in astrocytes","volume":"23","author":"Dasgupta","year":"2003","journal-title":"J Neurosci Off J Soc Neurosci"},{"issue":"18","key":"bib80","doi-asserted-by":"publisher","first-page":"8588","DOI":"10.1158\/0008-5472.CAN-06-2220","article-title":"Spatiotemporal differences in CXCL12 expression and cyclic AMP underlie the unique pattern of optic glioma growth in neurofibromatosis type 1","volume":"67","author":"Warrington","year":"2007","journal-title":"Cancer Res"},{"issue":"25","key":"bib81","doi-asserted-by":"publisher","first-page":"6712","DOI":"10.1093\/hmg\/ddu389","article-title":"Neuronal NF1\/Ras regulation of cyclic AMP requires atypical PKC activation","volume":"23","author":"Anastasaki","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"16","key":"bib82","doi-asserted-by":"publisher","first-page":"5579","DOI":"10.1523\/JNEUROSCI.3994-09.2010","article-title":"Defective cAMP generation underlies the sensitivity of CNS neurons to neurofibromatosis-1 heterozygosity","volume":"30","author":"Brown","year":"2010","journal-title":"J Neurosci"},{"issue":"5","key":"bib83","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1097\/NEN.0b013e3181a3240b","article-title":"Optic nerve dysfunction in a mouse model of neurofibromatosis-1 optic glioma","volume":"68","author":"Hegedus","year":"2009","journal-title":"J Neuropathol Exp Neurol"},{"issue":"6","key":"bib84","first-page":"808","article-title":"Defining the temporal course of murine neurofibromatosis-1 optic gliomagenesis reveals a therapeutic window to attenuate retinal dysfunction","volume":"19","author":"Toonen","year":"2017","journal-title":"Neuro-Oncol"},{"issue":"1","key":"bib85","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.tig.2008.10.012","article-title":"Co-evolution of tumor cells and their microenvironment","volume":"25","author":"Polyak","year":"2009","journal-title":"Trends Genet TIG"},{"issue":"7","key":"bib86","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nrc1653","article-title":"Neurofibromatosis type 1 - a model for nervous system tumour formation?","volume":"5","author":"Rubin","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"bib87","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1146\/pathmechdis.2006.1.issue-1","article-title":"Tumor stroma and regulation of cancer development","volume":"1","author":"Tlsty","year":"2006","journal-title":"Annu Rev Pathol"},{"issue":"4","key":"bib88","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s00401-021-02276-5","article-title":"Integrated molecular and clinical analysis of low-grade gliomas in children with neurofibromatosis type 1 (NF1)","volume":"141","author":"Fisher","year":"2021","journal-title":"Acta Neuropathol (Berl)"},{"issue":"1","key":"bib89","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/ana.v57:1","article-title":"Natural history of neurofibromatosis 1-associated optic nerve glioma in mice","volume":"57","author":"Bajenaru","year":"2005","journal-title":"Ann Neurol"},{"issue":"24","key":"bib90","doi-asserted-by":"publisher","first-page":"5577","DOI":"10.1242\/dev.02162","article-title":"Inactivation of NF1 in CNS causes increased glial progenitor proliferation and optic glioma formation","volume":"132","author":"Zhu","year":"2005","journal-title":"Development"},{"issue":"4","key":"bib91","first-page":"957","article-title":"Flow cytometric characterization of tumor-associated macrophages in experimental gliomas","volume":"46","author":"Badie","year":"2000","journal-title":"Neurosurgery"},{"issue":"2","key":"bib92","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1002\/glia.v40:2","article-title":"Microglia in brain tumors","volume":"40","author":"Graeber","year":"2002","journal-title":"Glia"},{"issue":"11","key":"bib93","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1038\/nn1997","article-title":"Microglia: active sensor and versatile effector cells in the normal and pathologic brain","volume":"10","author":"Hanisch","year":"2007","journal-title":"Nat Neurosci"},{"issue":"3","key":"bib94","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1007\/s004010050520","article-title":"Distribution and characterization of microglia\/macrophages in human brain tumors","volume":"92","author":"Roggendorf","year":"1996","journal-title":"Acta Neuropathol (Berl)"},{"issue":"7","key":"bib95","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1179\/016164105X49463a","article-title":"Role of microglia in the central nervous system's immune response","volume":"27","author":"Streit","year":"2005","journal-title":"Neurol Res"},{"issue":"9","key":"bib96","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1093\/hmg\/ddm059","article-title":"Neurofibromatosis-1 (Nf1) heterozygous brain microglia elaborate paracrine factors that promote Nf1-deficient astrocyte and glioma growth","volume":"16","author":"Daginakatte","year":"2007","journal-title":"Hum Mol Genet"},{"issue":"24","key":"bib97","doi-asserted-by":"crossref","first-page":"10358","DOI":"10.1158\/0008-5472.CAN-08-2506","article-title":"Increased c-Jun-NH2-kinase signaling in neurofibromatosis-1 heterozygous microglia drives microglia activation and promotes optic glioma proliferation","volume":"68","author":"Gc","year":"2008","journal-title":"Cancer Res"},{"issue":"3","key":"bib98","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/glia.v53:3","article-title":"Mouse model for ablation of proliferating microglia in acute CNS injuries","volume":"53","author":"Gowing","year":"2006","journal-title":"Glia"},{"issue":"1","key":"bib99","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1097\/NEN.0b013e3182032d37","article-title":"Neurofibromatosis-1 heterozygosity increases microglia in a spatially and temporally restricted pattern relevant to mouse optic glioma formation and growth","volume":"70","author":"Simmons","year":"2011","journal-title":"J Neuropathol Exp Neurol"},{"issue":"10","key":"bib100","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1093\/neuonc\/noz080","article-title":"Genetic and genomic alterations differentially dictate low-grade glioma growth through cancer stem cell-specific chemokine recruitment of T cells and microglia","volume":"21","author":"Guo","year":"2019","journal-title":"Neuro-Oncol"},{"issue":"9","key":"bib101","doi-asserted-by":"publisher","first-page":"4444","DOI":"10.1167\/iovs.08-3357","article-title":"Regulation of dynamic behavior of retinal microglia by CX3CR1 signaling","volume":"50","author":"Liang","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib102","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.brainres.2009.06.068","article-title":"Fractalkine and CX3CR1 are involved in the migration of intravenously grafted human bone marrow stromal cells toward ischemic brain lesion in rats","volume":"1287","author":"Zhu","year":"2009","journal-title":"Brain Res"},{"issue":"2","key":"bib103","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/ana.v73.2","article-title":"Reduced microglial CX3CR1 expression delays neurofibromatosis-1 glioma formation","volume":"73","author":"Pong","year":"2013","journal-title":"Ann Neurol"},{"issue":"1-2","key":"bib104","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jneuroim.2010.05.002","article-title":"CXCL12 alone is insufficient for gliomagenesis in Nf1 mutant mice","volume":"224","author":"Sun","year":"2010","journal-title":"J Neuroimmunol"},{"issue":"1","key":"bib105","doi-asserted-by":"publisher","first-page":"vdab194","DOI":"10.1093\/noajnl\/vdab194","article-title":"Immune deconvolution and temporal mapping identifies stromal targets and developmental intervals for abrogating murine low-grade optic glioma formation","volume":"4","author":"de Andrade Costa","year":"2022","journal-title":"Neuro-Oncol Adv"},{"issue":"7-8","key":"bib106","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1101\/gad.310797.117","article-title":"Athymic mice reveal a requirement for T-cell-microglia interactions in establishing a microenvironment supportive of Nf1 low-grade glioma growth","volume":"32","author":"Pan","year":"2018","journal-title":"Genes Dev"},{"issue":"10","key":"bib107","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.neo.2015.10.002","article-title":"RNA sequencing of tumor-associated microglia reveals Ccl5 as a stromal chemokine critical for neurofibromatosis-1 glioma growth","volume":"17","author":"Solga","year":"2015","journal-title":"Neoplasia"},{"issue":"1","key":"bib108","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1038\/s41467-020-15770-3","article-title":"Midkine activation of CD8+ T cells establishes a neuron-immune-cancer axis responsible for low-grade glioma growth","volume":"11","author":"Guo","year":"2020","journal-title":"Nat Commun"},{"issue":"1","key":"bib109","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1084\/jem.20160447","article-title":"Estrogen activation of microglia underlies the sexually dimorphic differences in Nf1 optic glioma-induced retinal pathology","volume":"214","author":"Toonen","year":"2017","journal-title":"J Exp Med"},{"issue":"11","key":"bib110","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1016\/j.celrep.2015.02.041","article-title":"Mouse low-grade gliomas contain cancer stem cells with unique molecular and functional properties","volume":"10","author":"Chen","year":"2015","journal-title":"Cell Rep"},{"issue":"2","key":"bib111","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s10689-015-9855-3","article-title":"Associations between allergic conditions and pediatric brain tumors in Neurofibromatosis type 1","volume":"15","author":"Porcelli","year":"2016","journal-title":"Fam Cancer"},{"issue":"1","key":"bib112","doi-asserted-by":"publisher","first-page":"7122","DOI":"10.1038\/s41467-021-27455-6","article-title":"Asthma reduces glioma formation by T cell decorin-mediated inhibition of microglia","volume":"12","author":"Chatterjee","year":"2021","journal-title":"Nat Commun"},{"issue":"2","key":"bib113","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.cell.2020.03.034","article-title":"Roadmap for the emerging field of cancer neuroscience","volume":"181","author":"Monje","year":"2020","journal-title":"Cell"},{"issue":"7775","key":"bib114","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/s41586-019-1563-y","article-title":"Electrical and synaptic integration of glioma into neural circuits","volume":"573","author":"Venkatesh","year":"2019","journal-title":"Nature"},{"issue":"11","key":"bib115","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1038\/mp.2015.48","article-title":"HCN channels are a novel therapeutic target for cognitive dysfunction in neurofibromatosis type 1","volume":"20","author":"Omrani","year":"2015","journal-title":"Mol Psychiatry"},{"issue":"1","key":"bib116","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.3390\/ijms16011429","article-title":"HCN channels\u2013modulators of cardiac and neuronal excitability","volume":"16","author":"Herrmann","year":"2015","journal-title":"Int J Mol Sci"},{"key":"bib117","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1146\/pharmtox.2020.60.issue-1","article-title":"Hyperpolarization-activated cyclic nucleotide-gated channels as drug targets for neurological disorders","volume":"60","author":"Santoro","year":"2020","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"1","key":"bib118","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1038\/s41467-022-30466-6","article-title":"Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1","volume":"13","author":"Anastasaki","year":"2022","journal-title":"Nat Commun"},{"issue":"7862","key":"bib119","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41586-021-03580-6","article-title":"NF1 mutation drives neuronal activity-dependent initiation of optic glioma","volume":"594","author":"Pan","year":"2021","journal-title":"Nature"},{"issue":"3","key":"bib120","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S0896-6273(01)00470-6","article-title":"Visual deprivation alters development of synaptic function in inner retina after eye opening","volume":"32","author":"Tian","year":"2001","journal-title":"Neuron"},{"issue":"4","key":"bib121","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.cell.2015.04.012","article-title":"Neuronal activity promotes glioma growth through neuroligin-3 secretion","volume":"161","author":"Venkatesh","year":"2015","journal-title":"Cell"},{"issue":"7673","key":"bib122","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/nature24014","article-title":"Targeting neuronal activity-regulated neuroligin-3 dependency in high-grade glioma","volume":"549","author":"Venkatesh","year":"2017","journal-title":"Nature"},{"issue":"5","key":"bib123","first-page":"314","article-title":"Vascularity and angiogenesis as predictors of growth in optic pathway\/hypothalamic gliomas","volume":"104","author":"Bartels","year":"2006","journal-title":"J Neurosurg"},{"issue":"1","key":"bib124","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.neuroscience.2010.06.017","article-title":"Ultrastructural characterization of the optic pathway in a mouse model of neurofibromatosis-1 optic glioma","volume":"170","author":"Kim","year":"2010","journal-title":"Neuroscience"},{"issue":"5","key":"bib125","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1111\/nan.2011.37.issue-5","article-title":"Vascular endothelial growth factor receptor 2 (VEGFR-2) signalling activity in paediatric pilocytic astrocytoma is restricted to tumour endothelial cells","volume":"37","author":"Sikkema","year":"2011","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"4","key":"bib126","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.stemcr.2020.03.007","article-title":"Human iPSC-derived neurons and cerebral organoids establish differential effects of germline NF1 gene mutations","volume":"14","author":"Anastasaki","year":"2020","journal-title":"Stem Cell Rep"},{"issue":"12","key":"bib127","doi-asserted-by":"publisher","first-page":"3518","DOI":"10.1093\/hmg\/ddv103","article-title":"Elucidating the impact of neurofibromatosis-1 germline mutations on neurofibromin function and dopamine-based learning","volume":"24","author":"Anastasaki","year":"2015","journal-title":"Hum Mol Genet"},{"issue":"2","key":"bib128","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1055\/s-2007-985136","article-title":"Familial spinal neurofibromatosis","volume":"38","author":"Pascual-Castroviejo","year":"2007","journal-title":"Neuropediatrics"},{"key":"bib129","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12902-015-0076-4","article-title":"Optic glioma and precocious puberty in a girl with neurofibromatosis type 1 carrying an R681X mutation of NF1: case report and review of the literature","volume":"15","author":"Kocova","year":"2015","journal-title":"BMC Endocr Disord"},{"issue":"9","key":"bib130","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1093\/hmg\/ddw039","article-title":"NF1 germline mutation differentially dictates optic glioma formation and growth in neurofibromatosis-1","volume":"25","author":"Toonen","year":"2016","journal-title":"Hum Mol Genet"},{"issue":"5","key":"bib131","doi-asserted-by":"publisher","first-page":"e192","DOI":"10.1212\/NXG.0000000000000192","article-title":"Children with 5'-end NF1 gene mutations are more likely to have glioma","volume":"3","author":"Anastasaki","year":"2017","journal-title":"Neurol Genet"},{"issue":"6","key":"bib132","doi-asserted-by":"publisher","first-page":"655","DOI":"10.4149\/neo_2013_084","article-title":"Clustering of mutations in the 5' tertile of the NF1 gene in Slovakia patients with optic pathway glioma","volume":"60","author":"Bolcekova","year":"2013","journal-title":"Neoplasma"},{"issue":"4","key":"bib133","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1136\/jmg.2010.081760","article-title":"A molecular analysis of individuals with neurofibromatosis type 1 (NF1) and optic pathway gliomas (OPGs), and an assessment of genotype-phenotype correlations","volume":"48","author":"Sharif","year":"2011","journal-title":"J Med Genet"},{"issue":"5","key":"bib134","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s00439-016-1646-x","article-title":"No correlation between NF1 mutation position and risk of optic pathway glioma in 77 unrelated NF1 patients","volume":"135","author":"Hutter","year":"2016","journal-title":"Hum Genet"},{"key":"bib135","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3389\/fgene.2018.00270","article-title":"Identification of mutation regions on NF1 responsible for high- and low-risk development of optic pathway glioma in neurofibromatosis type I","volume":"9","author":"Xu","year":"2018","journal-title":"Front Genet"},{"issue":"2","key":"bib136","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jns.2018.10.006","article-title":"Phenotypic expression of a spectrum of neurofibromatosis type 1 (NF1) mutations identified through NGS and MLPA","volume":"65","author":"Tsipi","year":"2018","journal-title":"J Neurol Sci"},{"issue":"11","key":"bib137","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1002\/humu.2013.34.issue-11","article-title":"NF1 molecular characterization and neurofibromatosis type I genotype-phenotype correlation: the French Experience","volume":"34","author":"Sabbagh","year":"2013","journal-title":"Hum Mutat"},{"issue":"3","key":"bib138","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s00401-010-0784-9","article-title":"PI3K\/AKT pathway alterations are associated with clinically aggressive and histologically anaplastic subsets of pilocytic astrocytoma","volume":"121","author":"Rodriguez","year":"2011","journal-title":"Acta Neuropathol (Berl)"},{"issue":"9","key":"bib139","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1097\/NEN.0b013e3182656ef8","article-title":"BRAF duplications and MAPK pathway activation are frequent in gliomas of the optic nerve proper","volume":"71","author":"Rodriguez","year":"2012","journal-title":"J Neuropathol Exp Neurol"},{"issue":"5","key":"bib140","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1093\/neuonc\/nou287","article-title":"The impact of coexisting genetic mutations on murine optic glioma biology","volume":"17","author":"Kaul","year":"2015","journal-title":"Neuro-Oncol"},{"issue":"10","key":"bib141","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1093\/neuonc\/noab138","article-title":"Reimagining pilocytic astrocytomas in the context of pediatric low-grade gliomas","volume":"23","author":"Milde","year":"2021","journal-title":"Neuro-Oncol"},{"issue":"1","key":"bib142","doi-asserted-by":"publisher","first-page":"12506","DOI":"10.1038\/s41598-018-30942-4","article-title":"MicroRNA (miR) 125b regulates cell growth and invasion in pediatric low grade glioma","volume":"8","author":"Yuan","year":"2018","journal-title":"Sci Rep"},{"issue":"2","key":"bib143","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s00401-013-1124-7","article-title":"Differential expression and methylation of brain developmental genes define location-specific subsets of pilocytic astrocytoma","volume":"126","author":"Lambert","year":"2013","journal-title":"Acta Neuropathol (Berl)"},{"issue":"2","key":"bib144","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1093\/neuonc\/nor206","article-title":"Arlm1 is a male-specific modifier of astrocytoma resistance on mouse Chr 12","volume":"14","author":"Amlin-Van Schaick","year":"2012","journal-title":"Neuro-Oncol"},{"issue":"3","key":"bib145","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/nan.2012.38.issue-3","article-title":"Low-grade gliomas as neurodevelopmental disorders: insights from mouse models of neurofibromatosis-1","volume":"38","author":"Thangarajh","year":"2012","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"2","key":"bib146","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s10048-006-0078-5","article-title":"Nf1 expression is dependent on strain background: implications for tumor suppressor haploinsufficiency studies","volume":"8","author":"Hawes","year":"2007","journal-title":"Neurogenetics"},{"issue":"35","key":"bib147","doi-asserted-by":"publisher","first-page":"13008","DOI":"10.1073\/pnas.0401236101","article-title":"Susceptibility to astrocytoma in mice mutant for Nf1 and Trp53 is linked to chromosome 11 and subject to epigenetic effects","volume":"101","author":"Reilly","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"bib148","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1002\/ana.v75.5","article-title":"Gender as a disease modifier in neurofibromatosis type 1 optic pathway glioma","volume":"75","author":"Fisher","year":"2014","journal-title":"Ann Neurol"},{"issue":"5","key":"bib149","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1007\/s10519-005-9040-9","article-title":"Academic impairment is the most frequent complication of neurofibromatosis type-1 (NF1) in children","volume":"36","author":"Coud\u00e9","year":"2006","journal-title":"Behav Genet"},{"issue":"7","key":"bib150","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1212\/01.wnl.0000179303.72345.ce","article-title":"The nature and frequency of cognitive deficits in children with neurofibromatosis type 1","volume":"65","author":"Hyman","year":"2005","journal-title":"Neurology"},{"issue":"9","key":"bib151","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1007\/s00381-020-04724-1","article-title":"A systematic review of ongoing clinical trials in optic pathway gliomas","volume":"36","author":"Hill","year":"2020","journal-title":"Childs Nerv Syst"},{"issue":"6","key":"bib152","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1093\/neuonc\/noaa036","article-title":"Implications of new understandings of gliomas in children and adults with NF1: report of a consensus conference","volume":"22","author":"Packer","year":"2020","journal-title":"Neuro-Oncol"},{"issue":"5","key":"bib153","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1200\/JCO.1993.11.5.850","article-title":"Carboplatin and vincristine for recurrent and newly diagnosed low-grade gliomas of childhood","volume":"11","author":"Packer","year":"1993","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"15","key":"bib154","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.2165\/00003495-200363150-00003","article-title":"Neurotoxic complications of chemotherapy in patients with cancer: clinical signs and optimal management","volume":"63","author":"Verstappen","year":"2003","journal-title":"Drugs"},{"issue":"10","key":"bib155","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1093\/neuonc\/nou059","article-title":"Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomas","volume":"16","author":"Karajannis","year":"2014","journal-title":"Neuro-Oncol"},{"issue":"7287","key":"bib156","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nature08833","article-title":"RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth","volume":"464","author":"Hatzivassiliou","year":"2010","journal-title":"Nature"},{"issue":"7287","key":"bib157","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/nature08902","article-title":"RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF","volume":"464","author":"Poulikakos","year":"2010","journal-title":"Nature"},{"issue":"7","key":"bib158","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/S1470-2045(19)30277-3","article-title":"Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial","volume":"20","author":"Fangusaro","year":"2019","journal-title":"Lancet Oncol"},{"issue":"8","key":"bib159","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1093\/neuonc\/now282","article-title":"A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study","volume":"19","author":"Banerjee","year":"2017","journal-title":"Neuro-Oncol"},{"issue":"4","key":"bib160","doi-asserted-by":"publisher","first-page":"e28833","DOI":"10.1002\/pbc.v68.4","article-title":"Visual outcomes following everolimus targeted therapy for neurofibromatosis type 1-associated optic pathway gliomas in children","volume":"68","author":"Ullrich","year":"2021","journal-title":"Pediatr Blood Cancer"},{"issue":"10","key":"bib161","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1093\/neuonc\/noaa071","article-title":"A phase II study of continuous oral mTOR inhibitor everolimus for recurrent, radiographic-progressive neurofibromatosis type 1-associated pediatric low-grade glioma: a Neurofibromatosis Clinical Trials Consortium study","volume":"22","author":"Ullrich","year":"2020","journal-title":"Neuro-Oncol"},{"issue":"1","key":"bib162","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/pbc.v60.1","article-title":"A feasibility and efficacy study of rapamycin and erlotinib for recurrent pediatric low-grade glioma (LGG)","volume":"60","author":"Yalon","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"bib163","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1593\/tlo.08178","article-title":"Ecological therapy for cancer: defining tumors using an ecosystem paradigm suggests new opportunities for novel cancer treatments","volume":"1","author":"Pienta","year":"2008","journal-title":"Transl Oncol"},{"issue":"2","key":"bib164","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1093\/neuonc\/not154","article-title":"Efficacy of bevacizumab plus irinotecan in children with recurrent low-grade gliomas\u2013a Pediatric Brain Tumor Consortium study","volume":"16","author":"Gururangan","year":"2014","journal-title":"Neuro-Oncol"},{"issue":"6","key":"bib165","doi-asserted-by":"publisher","first-page":"e341","DOI":"10.1097\/MPH.0000000000000371","article-title":"Confirmation of bevacizumab activity, and maintenance of efficacy in retreatment after subsequent relapse, in pediatric low-grade glioma","volume":"37","author":"Kalra","year":"2015","journal-title":"J Pediatr Hematol Oncol"},{"issue":"7","key":"bib166","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1002\/pbc.v52:7","article-title":"Objective response of multiply recurrent low-grade gliomas to bevacizumab and irinotecan","volume":"52","author":"Packer","year":"2009","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"bib167","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/cam4.2019.8.issue-1","article-title":"Use of bevacizumab as a single agent or in adjunct with traditional chemotherapy regimens in children with unresectable or progressive low-grade glioma","volume":"8","author":"Zhukova","year":"2019","journal-title":"Cancer Med"},{"issue":"1","key":"bib168","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1001\/jamaophthalmol.2013.5819","article-title":"Marked recovery of vision in children with optic pathway gliomas treated with bevacizumab","volume":"132","author":"Avery","year":"2014","journal-title":"JAMA Ophthalmol"},{"issue":"5","key":"bib169","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1002\/pbc.v60.5","article-title":"Long-term efficacy and toxicity of bevacizumab-based therapy in children with recurrent low-grade gliomas","volume":"60","author":"Hwang","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"bib170","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s00381-019-04407-6","article-title":"Bevacizumab for optic pathway glioma with worsening visual field in absence of imaging progression: 2 case reports and literature review","volume":"36","author":"Yamasaki","year":"2020","journal-title":"Childs Nerv Syst ChNS Off J Int Soc Pediatr Neurosurg"},{"issue":"4","key":"bib171","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1093\/neuonc\/noac223","article-title":"A nationwide evaluation of bevacizumab-based treatments in pediatric low-grade glioma in the UK: safety, efficacy, visual morbidity, and outcomes","volume":"25","author":"Green","year":"2023","journal-title":"Neuro-Oncol"},{"issue":"3","key":"bib172","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1200\/JCO.2010.31.3601","article-title":"Phase I trial of lenalidomide in pediatric patients with recurrent, refractory, or progressive primary CNS tumors: pediatric brain tumor consortium study PBTC-018","volume":"29","author":"Warren","year":"2011","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"8","key":"bib173","doi-asserted-by":"publisher","first-page":"976","DOI":"10.3390\/brainsci11080976","article-title":"Against the resilience of high-grade gliomas: gene therapies (part II)","volume":"11","author":"Giotta Lucifero","year":"2021","journal-title":"Brain Sci"},{"issue":"4","key":"bib174","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1001\/archopht.119.4.516","article-title":"Spontaneous regression of optic gliomas: thirteen cases documented by serial neuroimaging","volume":"119","author":"Parsa","year":"2001","journal-title":"Arch Ophthalmol Chic Ill 1960"},{"issue":"4","key":"bib175","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1215\/15228517-2007-031","article-title":"Visual outcome of a cohort of children with neurofibromatosis type 1 and optic pathway glioma followed by a pediatric neuro-oncology program","volume":"9","author":"Dalla Via","year":"2007","journal-title":"Neuro-Oncol"},{"issue":"Pt 2","key":"bib176","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/brain\/awv366","article-title":"Nerve growth factor improves visual loss in childhood optic gliomas: a randomized, double-blind, phase II clinical trial","volume":"139","author":"Falsini","year":"2016","journal-title":"Brain J Neurol"},{"issue":"4","key":"bib177","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/sj.gt.3302277","article-title":"Effect of GDNF gene transfer into axotomized retinal ganglion cells using in vivo electroporation with a contact lens-type electrode","volume":"12","author":"Ishikawa","year":"2005","journal-title":"Gene Ther"},{"issue":"2","key":"bib178","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/gt.2011.142","article-title":"Gene therapy for retinal ganglion cell neuroprotection in glaucoma","volume":"19","author":"Wilson","year":"2012","journal-title":"Gene Ther"},{"issue":"7665","key":"bib179","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/nature23283","article-title":"Stimulation of functional neuronal regeneration from M\u00fcller glia in adult mice","volume":"548","author":"Jorstad","year":"2017","journal-title":"Nature"},{"issue":"8","key":"bib180","doi-asserted-by":"publisher","first-page":"3104","DOI":"10.1172\/JCI85193","article-title":"Reprogramming M\u00fcller glia via in vivo cell fusion regenerates murine photoreceptors","volume":"126","author":"Sanges","year":"2016","journal-title":"J Clin Invest"},{"key":"bib181","doi-asserted-by":"publisher","first-page":"10472","DOI":"10.1038\/ncomms10472","article-title":"Transplanted neurons integrate into adult retinas and respond to light","volume":"7","author":"Venugopalan","year":"2016","journal-title":"Nat Commun"},{"issue":"11","key":"bib182","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1002\/glia.v57:11","article-title":"Microarray analyses reveal regional astrocyte heterogeneity with implications for neurofibromatosis type 1 (NF1)-regulated glial proliferation","volume":"57","author":"Yeh","year":"2009","journal-title":"Glia"},{"issue":"14","key":"bib183","doi-asserted-by":"publisher","first-page":"4650","DOI":"10.1158\/1078-0432.CCR-11-0127","article-title":"Genetic aberrations leading to MAPK pathway activation mediate oncogene-induced senescence in sporadic pilocytic astrocytomas","volume":"17","author":"Jacob","year":"2011","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"issue":"11","key":"bib184","doi-asserted-by":"publisher","first-page":"3590","DOI":"10.1158\/1078-0432.CCR-10-3349","article-title":"BRAF activation induces transformation and then senescence in human neural stem cells: a pilocytic astrocytoma model","volume":"17","author":"Raabe","year":"2011","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"issue":"6","key":"bib185","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1158\/1078-0432.CCR-18-1965","article-title":"The Senescence-associated Secretory Phenotype Mediates oncogene-induced senescence in pediatric pilocytic astrocytoma","volume":"25","author":"Buhl","year":"2019","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"issue":"10","key":"bib186","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1007\/s00381-006-0061-3","article-title":"Spontaneous regression of optic pathways gliomas in three patients with neurofibromatosis type I and critical review of the literature","volume":"22","author":"Piccirilli","year":"2006","journal-title":"Childs Nerv Syst"},{"key":"bib187","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.ebiom.2019.01.056","article-title":"Senolytics and senostatics as adjuvant tumour therapy","volume":"41","author":"Short","year":"2019","journal-title":"EBioMedicine"},{"issue":"4","key":"bib188","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1172\/JCI28271","article-title":"Harnessing preclinical mouse models to inform human clinical cancer trials","volume":"116","author":"Gutmann","year":"2006","journal-title":"J Clin Invest"},{"issue":"3","key":"bib189","doi-asserted-by":"publisher","first-page":"e26838","DOI":"10.1002\/pbc.v65.3","article-title":"Neurofibromatosis type 1 and optic pathway glioma: molecular interplay and therapeutic insights","volume":"65","author":"Khatua","year":"2018","journal-title":"Pediatr Blood Cancer"},{"issue":"11","key":"bib190","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.3390\/cancers11111790","article-title":"Optic pathway glioma in type 1 neurofibromatosis: review of its pathogenesis, diagnostic assessment, and treatment recommendations","volume":"11","author":"Cassina","year":"2019","journal-title":"Cancers"},{"issue":"1","key":"bib191","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s42003-018-0163-y","article-title":"Genetically engineered minipigs model the major clinical features of human neurofibromatosis type 1","volume":"1","author":"Isakson","year":"2018","journal-title":"Commun Biol"},{"issue":"2","key":"bib192","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1177\/0300985811402846","article-title":"Swine as models in biomedical research and toxicology testing","volume":"49","author":"Swindle","year":"2012","journal-title":"Vet Pathol"},{"issue":"4","key":"bib193","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/laban.1215","article-title":"Swine models, genomic tools and services to enhance our understanding of human health and diseases","volume":"46","author":"Walters","year":"2017","journal-title":"Lab Anim"},{"issue":"Pt B","key":"bib194","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.expneurol.2017.04.001","article-title":"Human stem cell modeling in neurofibromatosis type 1 (NF1)","volume":"299","author":"Wegscheid","year":"2018","journal-title":"Exp Neurol"},{"issue":"11","key":"bib195","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1038\/nm.4189","article-title":"Efficient derivation of microglia-like cells from human pluripotent stem cells","volume":"22","author":"Muffat","year":"2016","journal-title":"Nat Med"}],"container-title":["Investigative Ophthalmology & Visual Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2793726","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:31:56Z","timestamp":1791927116000},"score":1,"resource":{"primary":{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2793726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,5]]},"references-count":195,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6,3]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.65.6.8","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,5]]}}}